The Position of EGF Deprivation in the Management of Advanced Non-Small Cell Lung Cancer

Advanced non-small cell lung cancer (NSCLC) has faced a therapeutic revolution with the advent of tyrosine kinase inhibitors (TKIs) and immune checkpoints inhibitors (ICIs) approved for first and subsequent therapies. CIMAvax-EGF is a chemical conjugate between human-recombinant EGF and P64, a recom...

Descripción completa

Detalles Bibliográficos
Autores principales: Crombet Ramos, Tania, Santos Morales, Orestes, Dy, Grace K., León Monzón, Kalet, Lage Dávila, Agustín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240591/
https://www.ncbi.nlm.nih.gov/pubmed/34211836
http://dx.doi.org/10.3389/fonc.2021.639745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240591/
https://www.ncbi.nlm.nih.gov/pubmed/34211836
http://dx.doi.org/10.3389/fonc.2021.639745

Ejemplares similares